Patents/Assignees

Nikang Therapeutics, Inc.

9 patents in portfolio

US12435034utility2025
Process of Preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
0 cites
US12415779utility2025
Processes of Making 3-fluoro-5-(((1s,2ar)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and Polymorphs Thereof
0 cites
US12391642utility2025
Tetrahydro-1h-cyclopenta[cd]indene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
0 cites
US12331026utility2025
Sulfonamido Derivatives as Cyclin-dependent Kinase 2 Inhibitors
0 cites
US12264167utility2025
Fused Tricyclic Ring Derivatives as SRC Homology-2 Phosphate Inhibitors
0 cites
US12171741utility2024
2,3-dihydrobenzo[b]thiophene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
0 cites
US12077506utility2024
Indane Derivatives as Hypoxia Inducible Factor-2(α) Inhibitors
0 cites
US11753366utility2023
Tetrahydro-1h-cyclopenta[cd]indene Derivatives as Hypoxia Inducible Factor-2(alpha) Inhibitors
0 cites
US11634382utility2023
Process of Preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1h-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
0 cites